|
|
|
|
|
 |
|
Pharmaceuticals Sector |
|
 |
|
| Shaping up to a Changing Industry
Solvay Pharmaceuticals operates in two key therapeutic fields, in which it undertakes a full range of Research and Development activities:
These are supplemented by two niche areas in which Solvay is well-established, with extensive know-how:
- Flu vaccines
- Pancreatic enzymes
And by two other commercially important fields where existing products receive management and R&D support:
- Female and male hormone treatments
- Gastroenterology
 Sales Breakdown 2008: EUR 2 699 million
By therapeutic field
 By geographic area
|
- Europe
36% European Union (27)
10% Other European countries)
- The Americas
40% Nafta
2% Mercosur
- Asia-Pacific
- Rest of the world
|
46 %
42 %
8 %
4 % |
 R&D expenditure 2008: EUR 428 million
|
By therapeutic field
- Cardiometabolics
- Neuroscience
- Flu vaccines
- Pancreatic enzymes
- Female and male hormone treatments
|
35 %
36 %
6 %
14 %
9 % |
|
|
|
|
|
|
|
|
